Consistent with these findings, recent studies have underscored the role of MAP2K1 depletion in inhibiting the proliferation, migration, and invasion of cancer cells across diverse cancers, including hepatocellular carcinoma [35], gastric cancer [33], and esophageal squamous cell carcinoma [36]. The gene discussed is MAP2K1; the disease is gastric cancer.